Conformational Basis for SH2-Tyr(P)527 Binding in Src Inactivation
Overview
Affiliations
Src protein-tyrosine kinase contains a myristoylation motif, a unique region, an Src homology (SH) 3 domain, an SH2 domain, a catalytic domain, and a C-terminal tail. The C-terminal tail contains a Tyr residue, Tyr527. Phosphorylation of Tyr527 triggers Src inactivation, caused by Tyr(P)527 binding to the SH2 domain. In this study, we demonstrated that a conformational contribution, not affinity, is the predominant force for the intramolecular SH2-Tyr(P)527 binding, and we characterized the structural basis for this conformational contribution. First, a phosphopeptide mimicking the C-terminal tail is an 80-fold weaker ligand than the optimal phosphopeptide, pYEEI, and similar to a phosphopeptide containing three Ala residues following Tyr(P) in binding to the Src SH2 domain. Second, the SH2-Tyr(P)527 binding is largely independent of the amino acid sequence surrounding Tyr(P)527, and only slightly decreased by an inactivating mutation in the SH2 domain. Furthermore, even the unphosphorylated C-terminal tail with the sequence of YEEI suppresses Src activity by binding to the SH2 domain. These experiments demonstrate that very weak affinity is sufficient for the SH2-Tyr(P)527 binding in Src inactivation. Third, the effective intramolecular SH2-Tyr(P)527 binding is attributed to a conformational contribution that requires residues Trp260 and Leu255. Although the SH3 domain is essential for Src inactivation by Tyr(P)527, it does not contribute to the SH2-Tyr(P)527 binding. These findings suggest a conformation-based Src inactivation model, which provides a unifying framework for understanding Src activation by a variety of mechanisms.
Integrin and Its Associated Proteins as a Mediator for Mechano-Signal Transduction.
Katoh K Biomolecules. 2025; 15(2).
PMID: 40001469 PMC: 11853369. DOI: 10.3390/biom15020166.
Conformational buffering underlies functional selection in intrinsically disordered protein regions.
Gonzalez-Foutel N, Glavina J, Borcherds W, Safranchik M, Barrera-Vilarmau S, Sagar A Nat Struct Mol Biol. 2022; 29(8):781-790.
PMID: 35948766 PMC: 10262780. DOI: 10.1038/s41594-022-00811-w.
Anti-Survival Effect of SI306 and Its Derivatives on Human Glioblastoma Cells.
Monteleone L, Marengo B, Musumeci F, Grossi G, Carbone A, Valenti G Pharmaceutics. 2022; 14(7).
PMID: 35890294 PMC: 9318396. DOI: 10.3390/pharmaceutics14071399.
Chakraborty S, Inukai T, Fang L, Golkowski M, Maly D ACS Chem Biol. 2019; 14(6):1249-1259.
PMID: 31038916 PMC: 6642640. DOI: 10.1021/acschembio.9b00214.
Tong M, Pelton J, Gill M, Zhang W, Picart F, Seeliger M Nat Commun. 2017; 8(1):2160.
PMID: 29255153 PMC: 5735167. DOI: 10.1038/s41467-017-02240-6.